Canadian application, no grantCanada
Basb128 polypeptide and polynucleotide from moxarella catarrhalis
CA 2383292 A1 · Owner: Smithkline Beecham Biologicals S.A. · Inventors: Thonnard, Joelle
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides BASB128 polypeptides and polynucleotides encoding BASB128 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic prophylactic and , therapeutic uses.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 14, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 14, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 14, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 14, 2000
GrantedNo grant recorded
Term endedSeptember 14, 2020
Patent numberCA 2383292 A1
Classification (IPC)C12N15/31 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.